Issue 7 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

28

No.

7

February 15, 2002Feb 15, 2002

Free

DOWNLOAD THE PDF

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

ImClone Protocol Generates More Questions Than Answers.

Phase III Trial Would Give Clearer Picture Of C225 Role.

Thomas Jordan To Help ASCO Enhance International Relations, Retires From BMS.

Levine Leaves Presidency Of Rockefeller University.

Recent Issues

Volume 52 | Issue 32 - August 14, 2026

Volume 52 | Issue 31 - August 07, 2026

Volume 52 | Issue 30 - July 31, 2026

Volume 52 | Issue 29 - July 24, 2026

Volume 52 | Issue 28 - July 17, 2026

Volume 52 | Issue 27 - July 10, 2026